IPG PHOTONICS CORP — Form 8-K
Filed August 4, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 42/100
What the filing says
IPG Photonics reported Q2 2026 revenue of $278.6M (11% YoY growth), with adjusted gross margin of 40.7% (up 290bp YoY) and adjusted EPS of $0.58 (93% growth). Industrial Solutions grew 16%, while Advanced Solutions declined 9%. The company announced acquisition of Lumibird Medical to expand into medical markets. Q3 guidance: revenue $265–$295M; adjusted EPS $0.30–$0.60; adjusted EBITDA $35–$51M. Impairment charges of $17.6M in H1 2026 included.
Why this rating
Strong topline growth (11% YoY, 14% YTD) and margin expansion offset by guidance caution on tariffs/FX. Lumibird deal is strategic but unpriced here. Company scale ~$1.8B; $280M quarterly revenue is 15% of annual run-rate—material but not transformational. Q3 guidance midpoint ($280M revenue, $0.45 EPS) suggests moderation.
See more from August 4, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.